Cargando…
Etamycin as a Novel Mycobacterium abscessus Inhibitor
The increase in drug-resistant Mycobacterium abscessus, which has become resistant to existing standard-of-care agents, is a major concern, and new antibacterial agents are strongly needed. In this study, we introduced etamycin that showed an excellent activity against M. abscessus. We found that et...
Autores principales: | Hanh, Bui Thi Bich, Kim, Tae Ho, Park, June-Woo, Lee, Da-Gyum, Kim, Jae-Sung, Du, Young Eun, Yang, Chul-Su, Oh, Dong-Chan, Jang, Jichan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555287/ https://www.ncbi.nlm.nih.gov/pubmed/32967077 http://dx.doi.org/10.3390/ijms21186908 |
Ejemplares similares
-
Rifamycin O, An Alternative Anti-Mycobacterium abscessus Agent
por: Hanh, Bui Thi Bich, et al.
Publicado: (2020) -
Thiostrepton: A Novel Therapeutic Drug Candidate for Mycobacterium abscessus Infection
por: Kim, Tae Ho, et al.
Publicado: (2019) -
Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus
por: Bich Hanh, Bui Thi, et al.
Publicado: (2021) -
A Screening of the MMV Pandemic Response Box Reveals Epetraborole as A New Potent Inhibitor against Mycobacterium abscessus
por: Kim, Taeho, et al.
Publicado: (2021) -
The Peroxisome Proliferator-Activated Receptor α- Agonist Gemfibrozil Promotes Defense Against Mycobacterium abscessus Infections
por: Kim, Yi Sak, et al.
Publicado: (2020)